Seattle’s Infectious Disease Research Institute to coordinate the study of a novel COVID-19 treatment
Human trial will enroll approximately 100 patients with investigational immunotherapy developed by Celularity for cases of COVID-19 disease SEATTLE (PRWEB) APRIL 02, 2020 With more than 25 years of success in infectious disease research and development, the Infectious Disease Research Institute (IDRI) is poised make rapid and significant advances in developing a treatment[…]
Read more